Mindfulness-based cognitive therapy beneficial in diabetes

December 11, 2012
Mindfulness-based cognitive therapy beneficial in diabetes
For patients with diabetes and low levels of emotional well-being, mindfulness-based cognitive therapy improves emotional distress and health-related quality of life, according to a study published online Nov. 27 in Diabetes Care.

(HealthDay)—For patients with diabetes and low levels of emotional well-being, mindfulness-based cognitive therapy (MBCT) improves emotional distress and health-related quality of life, according to a study published online Nov. 27 in Diabetes Care.

In an effort to examine the effect of MBCT on emotional distress, health-related quality of life, and glycemic control, Jenny van Son, of Tilburg University in the Netherlands, and colleagues conducted a of 139 outpatients with type 1 or 2 diabetes and low levels of emotional well-being who received either MBCT (70 patients) or a waiting list (69 patients). At baseline and four and eight weeks of follow-up, assessments were conducted.

The researchers found that MBCT was significantly more effective at decreasing stress, depressive symptoms, and anxiety. MBCT also correlated with significantly improved physical and mental quality of life. MBCT had no significant effect on , but patients with elevated diabetes distress had a trend toward reduced diabetes distress in the MBCT versus control group (P = 0.07).

"To the best of our knowledge, this is the first randomized trial to find immediate effects of a mindfulness-based intervention on emotional well-being and quality of life in outpatients with type 1 and ," van Son and colleagues conclude.

Explore further: Meditation provides hope for people with depression

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Meditation provides hope for people with depression

April 21, 2009

(PhysOrg.com) -- People with severe and recurrent depression could benefit from a new form of therapy that combines ancient forms of meditation with modern cognitive behaviour therapy, early-stage research by Oxford University ...

Glycemic variability affects mood and quality of life

May 10, 2012

(HealthDay) -- Glycemic variability appears to be associated with lower quality of life and negative moods in women with type 2 diabetes, according to a study published in the March 30 issue of Diabetes Technology & Therapeutics.

Diverse forms of distress have distinct impact in diabetes

October 10, 2012

(HealthDay)—In primary care patients with type 2 diabetes, depressive symptoms (DS) are predictive of future lifestyle-oriented self-management behaviors, while diabetes-related distress (DRD) predicts glycemic control, ...

Recommended for you

Diets avoiding dry-cooked foods can protect against diabetes

August 24, 2016

Simple changes in how we cook could go a long way towards preventing diabetes, say researchers at the Icahn School of Medicine at Mount Sinai. A new randomized controlled trial, published online July 29 in the journal Diabetologia, ...

New study reveals a novel protein linked to type 2 diabetes

August 16, 2016

Findings from Boston University School of Medicine (BUSM), which appear in eLife, provide a possible explanation as to why most people who are obese develop insulin resistance and type 2 diabetes. A minority of obese individuals, ...

Gene variant explains differences in diabetes drug response

August 9, 2016

The first results from a large international study of patients taking metformin, the world's most commonly used type 2 diabetes drug, reveal genetic differences among patients that may explain why some respond much better ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.